Up-Close With Oncotarget: The United States’ Leading Online Research Platform

Oncotarget is widely considered to be a modern and comprehensive research platform garnering immense recognition and popularity worldwide. Unlike other research cites, Oncotarget strives to deliver exceptional scientific discoveries across various disciplines. However, such results majorly revolve around biomedical science, and researchers must adhere to certain guidelines before their articles can be considered for review and publishing on the site and more information click here.

Since its inception, Oncotarget has successfully launched various sections beyond oncology to be betterment of readers. In essence, oncotarget refers to an all-inclusive term that includes pathways, cellular functions, microbes, neurons and molecules in various proportions. The research platform strives to foster reliable applications built upon concrete clinical science discoveries.

Oncotarget’s success is widely credited to its insightful leadership that has gone above and beyond to sensitize on the need for progressive science discoveries. Such leaders work round-the-clock to achieve the platform’s ultimate dream: Life without disease and learn more about Oncotarget.

 

Sections Studied Beyond Oncology

  • Gerotarget: Also known as Aging, this section primarily focuses on crucial components such as cellular senescence, atherosclerosis and Alzheimer’s among others. This section requires researchers to present detailed information that spells any doubt on their validity before making any formal submissions and Oncotarget on Facebook.

 

  • Pathology: Based on oncology’s dramatic popularity, Oncotarget’s pioneers deemed it necessary to pursue pathology courtesy of its critical benefits as outlined below:
  1. Higher impact factor
  2. Ultra-rapid publication

iii. Once submitted, the final decision is made within 6 days.

 

  • Immunology and microbiology: This section primarily publishes clinical and basic research including immune cell development, gene regulation, signal transduction and antigen recognition. Typically, the section strives to delve into immunotherapy, microbiology and hypersensitivities among others and Oncotarget’s lacrosse camp.

 

  • Autophagy and Cell Death: this section uniquely focuses on the significant strides made in key areas of translational and basic research, which mostly covers topics such as ATG proteins, Autophagy, Apoptosome Signaling and Bioenergetic Metabolism. To be considered for review, researchers must extensively cover their precise of research while also directing their manuscripts to the Section’s Editor.

 

Enforcement of Ethics and Publication Malpractices

 

Oncotarget strictly complies with the Code of Conduct and Best Practice Guidelines for Journal Editors, or simply known as COPE. In such a case, editors are required to exclusively review manuscripts on the basis of scientific merit which includes conclusions based on data and the provision of high-quality data regardless of the author’s background or gender.